Bjorkeson Dagmar Rosa

Insider Reports History

Entity
Individual
Location
C/O Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bjorkeson Dagmar Rosa:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xencor Inc Director Common Stock 8.49K $176K $20.68 Sep 27, 2024 Direct
Xencor Inc Director Stock Option (Right to Buy) 12K Jun 13, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Bjorkeson Dagmar Rosa

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XNCR Xencor Inc Sep 27, 2024 1 -$51.8K 4 Oct 1, 2024 Director
XNCR Xencor Inc Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 5 -$501K 4 Nov 13, 2023 Director
XNCR Xencor Inc Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
XNCR Xencor Inc Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
XNCR Xencor Inc Jun 24, 2021 1 $0 4 Jun 25, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director